Wells Fargo’s Baudax Bio, Inc. Common Stock BXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-53
| Closed | -$20 | – | 7345 |
|
|
2023
Q3 | $20 | Buy |
53
+9
| +20% | +$3 | ﹤0.01% | 6834 |
|
|
2023
Q2 | $51 | Buy |
44
+41
| +1,367% | +$48 | ﹤0.01% | 6741 |
|
|
2023
Q1 | $5 | Hold |
3
| – | – | ﹤0.01% | 7279 |
|
|
2022
Q4 | $10 | Buy |
3
+2
| +200% | +$7 | ﹤0.01% | 7050 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 7624 |
|
|
2022
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 7689 |
|
|
2022
Q1 | – | Sell |
-1
| Closed | – | – | 7708 |
|
|
2021
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 7625 |
|
|
2021
Q3 | $1K | Sell |
1
-2
| -67% | -$2K | ﹤0.01% | 6552 |
|
|
2021
Q2 | $3K | Buy |
3
+2
| +200% | +$2K | ﹤0.01% | 6164 |
|
|
2021
Q1 | $2K | Sell |
1
-1
| -50% | -$2K | ﹤0.01% | 6294 |
|
|
2020
Q4 | $2K | Sell |
2
-36
| -95% | -$36K | ﹤0.01% | 5973 |
|
|
2020
Q3 | $147K | Sell |
38
-22
| -37% | -$85.1K | ﹤0.01% | 4927 |
|
|
2020
Q2 | $348K | Sell |
60
-53
| -47% | -$307K | ﹤0.01% | 4445 |
|
|
2020
Q1 | $393K | Buy |
113
+100
| +769% | +$348K | ﹤0.01% | 4090 |
|
|
2019
Q4 | $129K | Buy |
+13
| New | +$129K | ﹤0.01% | 4998 |
|